Nonoperative Management Protocol in Patients With Blunt Splenic Injuries
- Conditions
- Blunt Injuries
- Interventions
- Other: Patient before cohort (2005-2010)Other: Patient after cohort (2011-2016)
- Registration Number
- NCT03943355
- Lead Sponsor
- Chang Gung Memorial Hospital
- Brief Summary
This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period in our institution.
- Detailed Description
The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 399
- Adult trauma patients with blunt splenic injury who were admitted from 2005 to 2016.
- Patients younger than 16 years
- Patients who died in the emergency department
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Nonoperative management protocol with angioembolization Patient after cohort (2011-2016) The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period. Nonoperative management protocol with angioembolization Patient before cohort (2005-2010) The nonoperative management (NOM) protocol with angioembolization (AE) presents a trend in dealing with trauma patients with blunt splenic injury (BSI). This study was designed to explore the adverse events and associated risk factors before and after protocol-based NOM of BSI over a 12-year period.
- Primary Outcome Measures
Name Time Method The numbers of associated complications and mortality up to 6 months The primary outcome of interest in this study would be the associated complications and mortality.
- Secondary Outcome Measures
Name Time Method